Short Interest in Auna S.A. (NYSE:AUNA) Expands By 40.1%

Auna S.A. (NYSE:AUNA) saw a significant growth in short interest in the month of February. As of February 27th, there was short interest totaling 436,807 shares, a growth of 40.1% from the February 12th total of 311,888 shares. Based on an average daily volume of 590,559 shares, the short-interest ratio is currently 0.7 days. Currently, 0.6% of the shares of the stock are short sold. Currently, 0.6% of the shares of the stock are short sold. Based on an average daily volume of 590,559 shares, the short-interest ratio is currently 0.7 days.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the company. Jefferies Financial Group started coverage on Auna in a report on Friday, January 16th. They issued a “buy” rating and a $9.00 target price for the company. Zacks Research raised Auna from a “strong sell” rating to a “strong-buy” rating in a research note on Monday, February 9th. Weiss Ratings reiterated a “sell (d)” rating on shares of Auna in a report on Monday, December 29th. HSBC upgraded shares of Auna from a “hold” rating to a “buy” rating and set a $6.90 target price on the stock in a research report on Wednesday, January 21st. Finally, Wall Street Zen upgraded shares of Auna from a “buy” rating to a “strong-buy” rating in a report on Saturday, February 28th. Two equities research analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Auna presently has a consensus rating of “Moderate Buy” and an average target price of $7.30.

Auna Price Performance

Auna stock opened at $5.07 on Monday. The stock’s 50 day moving average is $4.97 and its 200 day moving average is $5.41. Auna has a one year low of $4.46 and a one year high of $7.50. The firm has a market cap of $375.23 million, a P/E ratio of 14.08 and a beta of 2.08. The company has a debt-to-equity ratio of 1.87, a current ratio of 1.11 and a quick ratio of 1.01.

Auna (NYSE:AUNA) last announced its earnings results on Tuesday, March 10th. The company reported $0.53 EPS for the quarter, beating the consensus estimate of $0.11 by $0.42. Auna had a return on equity of 19.23% and a net margin of 2.13%.The company had revenue of $336.67 million for the quarter, compared to analyst estimates of $1.08 billion. As a group, research analysts expect that Auna will post 0.5 EPS for the current year.

Institutional Investors Weigh In On Auna

Institutional investors and hedge funds have recently made changes to their positions in the business. Marshall Wace LLP grew its holdings in shares of Auna by 391.0% during the fourth quarter. Marshall Wace LLP now owns 162,992 shares of the company’s stock worth $802,000 after purchasing an additional 129,799 shares in the last quarter. Hohimer Wealth Management LLC purchased a new position in Auna in the 2nd quarter worth $264,000. Jane Street Group LLC bought a new stake in Auna in the fourth quarter worth $201,000. Fiera Capital Corp boosted its position in Auna by 2.7% during the second quarter. Fiera Capital Corp now owns 1,558,358 shares of the company’s stock valued at $9,662,000 after buying an additional 40,673 shares during the period. Finally, Squarepoint Ops LLC purchased a new position in shares of Auna in the fourth quarter worth about $196,000.

About Auna

Auna, listed on the New York Stock Exchange under the ticker symbol AUNA, is a Peruvian integrated healthcare services company headquartered in Lima. The firm operates a diversified care network that spans hospitals, outpatient medical centers, diagnostic imaging and laboratory facilities, as well as optical and dental clinics. Auna’s organizational structure is designed to support a continuum of care model, offering both general and specialized treatments across multiple touchpoints.

The company delivers a broad range of clinical services, including emergency care, inpatient and outpatient surgery, obstetrics, cardiology, oncology, orthopedics, and other specialized disciplines.